| Literature DB >> 35484362 |
Hideo Tomihara1, Kazuhiko Hashimoto2, Hajime Ishikawa2, Daisuke Terashita2, Atsushi Gakuhara2, Shuichi Fukuda2, Katsuya Ohta2, Kotaro Kitani2, Jin-Ichi Hida2, Tomoko Wakasa3, Yutaka Kimura2.
Abstract
BACKGROUND: Undifferentiated carcinoma is a very rare histologic subtype, representing only 0.8% to 5.7% of all pancreatic exocrine neoplasms. Additionally, spontaneous abdominal hemorrhage is a particularly rare, life-threatening cause. CASEEntities:
Keywords: Osteoclast-like giant cell; Spontaneous rupture; Undifferentiated carcinoma
Year: 2022 PMID: 35484362 PMCID: PMC9051011 DOI: 10.1186/s40792-022-01437-2
Source DB: PubMed Journal: Surg Case Rep ISSN: 2198-7793
Patient’s laboratory data at admission
| Laboratory test | Value | Normal range | Unit |
|---|---|---|---|
| White blood cells | 6480 | 3300–8600 | /uL |
| Red blood cells | 426 × 104 | 386–492 × 104 | /uL |
| Hemoglobin | 12.4 | 11.6–14.8 | g/dL |
| Platelets | 20.3 × 104 | 15.8–34.8 × 104 | /uL |
| Prothrombin time | 109.7 | 80–120 | % |
| Sodium | 136 | 138–145 | mEq/L |
| Potassium | 5.8 | 3.6–4.8 | mEq/L |
| Chloride | 103 | 101–108 | mEq/L |
| Total protein | 6.8 | 6.6–8.1 | g/dL |
| Albumin | 4.0 | 4.1–5.1 | g/dL |
| Total bilirubin | 0.6 | 0.4–1.5 | mg/dL |
| Aspartate aminotransferase | 53 | 13–30 | /uL |
| Alanine aminotransferase | 20 | 7–23 | /uL |
| Alkaline phosphatase | 209 | 106–322 | /uL |
| Gamma-glutamyl transpeptidase | 24 | 9–32 | /uL |
| Lactate dehydrogenase | 492 | 124–222 | /uL |
| Cholinesterase | 289 | 201–421 | /uL |
| Total cholesterol | 133 | 142–220 | mg/dL |
| Triglyceride | 52 | 30–150 | mg/dL |
| Blood urea nitrogen | 22.9 | 8–20 | mg/dL |
| Creatinine | 0.9 | 0.46–0.79 | mg/dL |
| Hepatitis B surface antigen | Negative | Negative | |
| Hepatitis C virus antibody | Negative | Negative | |
| Alfa-fetoprotein | 2.6 | 0–10 | ng/mL |
| Carcinoembryonic antigen | 2.4 | 0–5 | ng/mL |
| Carbohydrate antigen 19–9 | 7.6 | 0–37 | U/mL |
| Protein induced by vitamin K absence or antagonist-II | 27 | 0–39 | mAU/mL |
| Hemoglobin A1c | 9.0 | 4.6–6.2 | % |
Fig. 1a Contrast-enhanced computed tomography of the abdomen showed a tumor with a maximum length of 99 mm in the pancreatic tail with enhanced rim staining in the peripheral area in the arterial phase (arrow). b The point of extravasation from the tumor (arrow top). c The coronal plane in the portal vein phase
Fig. 2Intraoperative photograph demonstrating the cystic tumor (yellow allows). The cystic tumor in the pancreatic tail was ruptured, and active bleeding was detected at the top of the tumor (dashed line)
Fig. 3Photographs of the surgical specimen. a Macroscopically, the tumor was multilocular-cystic and well-defined; hemorrhage was present, and the tumor had a septum. b The divided surface of the tumor (arrows)
Fig. 4Histopathological findings of the resected specimen. a Hematoxylin and eosin, ×40. Scale bar = 500 µm. The site of the rupture (arrow). Intra-tumoral hemorrhage (arrowhead). b Hematoxylin and eosin, ×200. Non-neoplastic osteoclast-like giant cells were present (square). Scale bar = 200 µm. c Hematoxylin and eosin, ×200. Round to spindle-shaped, highly pleomorphic mononuclear cells as well as a component of ductal adenocarcinoma were seen. Scale bar = 200 µm. d Elastic fiber staining, ×40. Scale bar = 500 µm. Extensive tumor infiltration into the splenic vein was present (yellow circle). e Immunohistochemical examination showed that the tumor cells were negative for cytokeratin AE1/AE3, ×40. Scale bar = 500 µm. f The non-neoplastic osteoclast-like giant cells were positive for CD68 (square), ×40. Scale bar = 500 µm